|
SOAT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.066200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.754830E-01 |
| Normal-vs-Stage2 |
5.337000E-03 |
| Normal-vs-Stage3 |
1.227240E-01 |
| Normal-vs-Stage4 |
2.030600E-01 |
| Stage1-vs-Stage2 |
6.802400E-02 |
| Stage1-vs-Stage3 |
7.445000E-01 |
| Stage1-vs-Stage4 |
7.027000E-01 |
| Stage2-vs-Stage3 |
1.622810E-01 |
| Stage2-vs-Stage4 |
2.937600E-01 |
| Stage3-vs-Stage4 |
9.060800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.688050E-01 |
| Normal-vs-AfricanAmerican |
7.758000E-01 |
| Normal-vs-Asian |
1.456160E-02 |
| Caucasian-vs-AfricanAmerican |
6.004800E-01 |
| Caucasian-vs-Asian |
9.057500E-02 |
| AfricanAmerican-vs-Asian |
1.169230E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.386300E-02 |
| Normal-vs-Female |
1.066160E-01 |
| Male-vs-Female |
6.238000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.342800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.030400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.285000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.194000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.182600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.187000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.683400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.312000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.724200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.078200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.610400E-01 |
| Classical-VS-Follicular |
6.98819999978006E-07 |
| Classical-VS-Other |
4.359800E-02 |
| Classical-VS-Normal |
4.426200E-01 |
| Tall-VS-Follicular |
3.979500E-03 |
| Tall-VS-Other |
3.859900E-02 |
| Tall-VS-Normal |
5.761600E-01 |
| Follicular-VS-Other |
5.133000E-01 |
| Follicular-VS-Normal |
2.44219999999684E-05 |
| Other-VS-Normal |
7.837800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.488320E-02 |
| Normal-vs-N1 |
1.340070E-02 |
| N0-vs-N1 |
5.405600E-01 |
|
|
